Windtree Therapeutics, Inc. (WINT)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Jul 30, 2026
Windtree Therapeutics Market Cap
Windtree Therapeutics has a market cap or net worth of $9 thousand as of July 31, 2026. Its market cap has decreased by -99.91% in one year.
Market Cap
9.00K
Enterprise Value
3.29M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since November 26, 1997, Windtree Therapeutics's market cap has decreased from 4.17B to 9.00K, a decrease of -100.00%. That is a compound annual growth rate of -36.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 9.00K | -99.22% |
| Dec 31, 2025 | 1.16M | -70.01% |
| Dec 31, 2024 | 3.86M | 4.27% |
| Dec 29, 2023 | 3.70M | -43.61% |
| Dec 30, 2022 | 6.56M | -85.53% |
| Dec 31, 2021 | 45.36M | -47.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NanoLogix | 13.03K |
| ObsEva | 11.72K |
| Biostax | 10.77K |
| Syros Pharmaceuticals | 10.73K |
| Trevena | 10.64K |
| GeneLink | 10.60K |
| Bioasis Technologies | 7.94K |
| Statera Biopharma | 7.26K |